TB Notes Newsletter
No. 3, 2013
NEW CDC PUBLICATIONS
Bamrah S, Yelk Woodruff RS, Powell K, Ghosh S, Kammerer JS, Haddad MB. Tuberculosis among the homeless, United States, 1994–2010. Int J Tuberc Lung Dis 2013 September 12; e-publication ahead of print; http://dx.doi.org/10.5588/ijtld.13.0270.
Bell TR, Molinari NM, Blumensaadt S, Selent MU, Arbisi M, Shah N, Christiansen D, Philen R, Puesta B, Jones J, Lee D, Vang A, Cohen NJ. Impact of port of entry referrals on initiation of follow-up evaluations for immigrants with suspected tuberculosis: Illinois. J Immigrant Minority Health 2013; 15:673–679; DOI 10.1007/s10903-013-9779-7.
Christian KA, Ijaz K, Dowell SF, Chow CC, Chitale RA, Bresee JS, Mintz E, Pallansch MA, Wassilak S, McCray E, Arthur RR. What we are watching—five top global infectious disease threats, 2012: a perspective from CDC’s Global Disease Detection Operations Center. Emerg Health Threats J 2013; 6: 20632; http://dx.doi.org/10.3402/ehtj.v6i0.20632.
Dilraj A, Bristow CC, Connolly C, Margot B, Dlamini S, Podewils LJ. Validation of sputum smear results in the Electronic TB Register for the management of tuberculosis, South Africa. Int J Tuberc Lung Dis 2013 Oct. 1; 17 (10): 1317-1321.
Dirac MA, Weigel KM, Yakrus MA, Becker AL, Chen H-L, Fridley G, Sikora A, Speake C, Hilborn ED, Pfaller S, Cangelosi GA. Shared Mycobacterium avium genotypes observed among unlinked clinical and environmental isolates. Applied and Environmental Microbiology 2013; epublished June 28, 2013.
Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox H, Holtz TH, Hollm-Delgado MG, Keshavjee S, Deriemer K, Centis R, D'Ambrosio L, Lange C, Bauer M, Menzies D. Resistance to fluoroquinolones and second-line injectable drugs: impact on MDR-TB outcomes. Eur Respir J 2013; 42: 156–168. DOI: 10.1183/09031936.00134712.
Hey SP, Heilig CM, Weijer C. Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program. Trials 2013; 14:159; www.trialsjournal.com/content/14/1/159.
Kammerer JS, Shang N, Althomsons SP, Haddad MB, Grant J, Navin TR. Using statistical methods and genotyping to detect tuberculosis outbreaks. Int J Health Geogr 2013 Mar 16; 12: 15. DOI: 10.1186/1476-072X-12-15.
Kerkhoff AD, Gupta A, Samandari T, Lawn SD. The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a greater or equal to 5 mm or a greater or equal to 10 mm cut-off: a systematic review. BMC Infect Dis 2013 Jul 8;13(1):307. [Epub ahead of print].
Migliori GB, Sotgiu G, Gandhi NR, Falzon D, Deriemer K, Centis R, Hollm-Delgado MG, Palmero D, Pérez-Guzmán C, Vargas MH, D'Ambrosio L, Spanevello A, Bauer M, Chan ED, Schaaf HS, Keshavjee S, Holtz TH, Menzies D; The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Drug resistance beyond XDR-TB: results from a large individual patient data meta-analysis. Eur Respir J 2013; 42: 169–179. DOI: 10.1183/09031936.00136312.
Moonan PK, Weis SE. Caveat emptor? Meta‐analysis of studies comparing self‐observed therapy and directly observed therapy for tuberculosis. CID 2013; online pub ahead of print June 27, 2013.
Podewils LJ, Gler MTS, Quelapio MI, Chen MP. Patterns of treatment interruption among patients with multidrug-resistant TB (MDR TB) and association with interim and final treatment outcomes. PLoS ONE 2013; 8(7): e70064. doi:10.1371/journal.pone.0070064.
Tollefson D, Bloss E, Fanning A, Redd JT, Barker K, McCray E. Burden of tuberculosis in indigenous peoples globally: a systematic review. [Review article]. Int J Tuberc Lung Dis 2013 Sept 1; 17 (9): 1139-1150.